Related Experiment Video
Updated: Jul 6, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Midkine is expressed by infiltrating macrophages in in-stent restenosis in hypercholesterolemic rabbits
Hiroshi Narita1, Sen Chen, Kimihiro Komori
1Department of Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Background:
Neointimal hyperplasia is strikingly suppressed in an endothelium injury model in mice deficient in the growth factor midkine. Knockdown of midkine expression by means of antisense oligonucleotide or small interfering RNA has been shown to lead to suppression of neointimal hyperplasia in a balloon injury model and a rabbit vein graft model; therefore, midkine is an essential factor for neointimal hyperplasia. These findings, however, do not necessarily apply to the function of midkine in vascular stenoses such as in-stent restenosis, because human vascular stenosis is often accompanied by atherosclerosis.
Methods:
We investigated midkine expression in the neointima induced by implantation of a bare metal stent in the atheromatous lesions of hypercholesterolemic rabbits. We analyzed midkine expression during a THP-1 cell differentiation and in peritoneal macrophages exposed to low-density lipoprotein or oxidized low-density lipoprotein.
Results:
Midkine expression reached the maximum level within 7 days after stenting and was detected in infiltrating macrophages. Differentiation of THP-1 cells to macrophage-like cells did not trigger midkine expression. Neither low-density lipoprotein nor oxidized low-density lipoprotein enhanced midkine expression in peritoneal macrophages that had been activated by thioglycollate, although these cells expressed a significant amount of midkine.
Conclusion:
The results indicate that macrophages are the major source of midkine in the atherosclerotic neointima. The amount of midkine expressed in macrophages may be sufficient (ie, further enhancement of the expression is not necessary) for the pathogenesis, because oxidized low-density lipoprotein stimulation did not induce the midkine expression.
Clinical Relevance:
The growth factor midkine is induced during vascular stenosis in mouse and rat models with normal diet. Knockdown of midkine expression suppresses neointimal hyperplasia. The vascular response after stenting differs from that after balloon injury in that the inflammation is more prolonged and the accumulation of macrophages is more abundant in stent-injured vessel. We found here that macrophages are the major source of midkine in the atherosclerotic neointima of in-stent restenosis in hypercholesterolemic rabbits. Our data suggest that midkine has an important role in in-stent restenosis of atherosclerotic vessels and is a candidate molecular target to prevent in-stent restenosis.
Insights
Midkine, a growth factor, is crucial for neointimal hyperplasia in atherosclerotic vessels. Macrophages are identified as the primary source of midkine in in-stent restenosis, suggesting it as a therapeutic target.
Area of Science:
- Vascular Biology
- Cardiovascular Research
- Molecular Medicine
Background:
- Neointimal hyperplasia is suppressed in midkine-deficient mice.
- Midkine is essential for neointimal hyperplasia in balloon injury and vein graft models.
- Its role in atherosclerotic vascular stenosis, like in-stent restenosis, remains unclear.
Purpose of the Study:
- To investigate midkine expression in the neointima of stented atherosclerotic lesions.
- To determine the cellular source and regulation of midkine in this context.
Main Methods:
- Examined midkine expression in rabbit neointima after stenting.
- Analyzed midkine expression in THP-1 cells and peritoneal macrophages exposed to lipids.
Main Results:
- Midkine expression peaked at 7 days post-stenting and was found in macrophages.
- THP-1 cell differentiation did not induce midkine expression.
- Lipid exposure did not enhance midkine expression in activated macrophages.
Conclusions:
- Macrophages are the main source of midkine in atherosclerotic neointima.
- Midkine's role in in-stent restenosis is significant.
- Midkine is a potential molecular target for preventing in-stent restenosis.